{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T18:53:40Z","timestamp":1787252020889,"version":"build-2736575974"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41401-026-01748-2","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T07:44:57Z","timestamp":1770968697000},"page":"1517-1532","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["MPTP and rotenone cause dopaminergic neuronal death by increasing DDIT4 promoter lactylation"],"prefix":"10.1038","volume":"47","author":[{"given":"Jing-chao","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-shu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-han","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-juan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-fang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-qiong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-long","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo-hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"1748_CR1","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1056\/NEJM199810153391607","volume":"339","author":"AE Lang","year":"1998","unstructured":"Lang AE, Lozano AM. Parkinson\u2019s disease. N Engl J Med. 1998;339:1130\u201343.","journal-title":"N Engl J Med"},{"key":"1748_CR2","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","volume":"339","author":"L AE","year":"1998","unstructured":"AE L. Parkinson\u2019s disease. First of two parts. N Engl J Med. 1998;339:1044\u201353.","journal-title":"N Engl J Med"},{"key":"1748_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31168-9","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu Z, Yang N, Dong J, Tian W, Chang L, Ma J, et al. Deficiency in endocannabinoid synthase DAGLB contributes to early onset Parkinsonism and murine nigral dopaminergic neuron dysfunction. Nat Commun. 2022;13:3490.","journal-title":"Nat Commun"},{"key":"1748_CR4","doi-asserted-by":"crossref","unstructured":"Guo JF, Zhang L, Li K, Mei JP, Xue J, Chen J, et al. Coding mutations in NUS1 contribute to Parkinson\u2019s disease. Proc Natl Acad Sci USA. 2018;115:11567\u201372.","DOI":"10.1073\/pnas.1809969115"},{"key":"1748_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/jnc.13593","volume":"139","author":"DG Hernandez","year":"2016","unstructured":"Hernandez DG, Reed X, Singleton AB. Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance. J Neurochem. 2016;139:59\u201374.","journal-title":"J Neurochem"},{"key":"1748_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/ana.21415","volume":"65","author":"C Paisan-Ruiz","year":"2009","unstructured":"Paisan-Ruiz C, Bhatia KP, Li A, Hernandez D, Davis M, Wood NW, et al. Characterization of PLA2G6 as a locus for dystonia-parkinsonism. Ann Neurol. 2009;65:19\u201323.","journal-title":"Ann Neurol"},{"key":"1748_CR7","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, et al. Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology. Neuron. 2004;44:601\u20137.","journal-title":"Neuron"},{"key":"1748_CR8","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1126\/science.1096284","volume":"304","author":"EM Valente","year":"2004","unstructured":"Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, et al. Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1. Science. 2004;304:1158\u201360.","journal-title":"Science"},{"key":"1748_CR9","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","volume":"44","author":"C Pais\u00e1n-Ru\u0131\u0301z","year":"2004","unstructured":"Pais\u00e1n-Ru\u0131\u0301z C, Jain S, Evans EW, Gilks WP, Sim\u00f3n J, Van Der Brug M, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson\u2019s disease. Neuron. 2004;44:595\u2013600.","journal-title":"Neuron"},{"key":"1748_CR10","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1126\/science.1077209","volume":"299","author":"V Bonifati","year":"2003","unstructured":"Bonifati V, Rizzu P, van Baren M, Schaap O, Breedveld G, Krieger E, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset Parkinsonism. Science. 2003;299:256\u20139.","journal-title":"Science"},{"key":"1748_CR11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/8820","volume":"22","author":"S Engelender","year":"1999","unstructured":"Engelender S, Kaminsky Z, Guo X, Sharp AH, Amaravi RK, Kleiderlein JJ, et al. Synphilin-1 associates with \u03b1-synuclein and promotes the formation of cytosolic inclusions. Nat Genet. 1999;22:110\u20134.","journal-title":"Nat Genet"},{"key":"1748_CR12","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998;392:605\u20138.","journal-title":"Nature"},{"key":"1748_CR13","doi-asserted-by":"crossref","unstructured":"Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R, Goedert M. \u03b1-Synuclein in Lewy bodies. Nature. 1997;388:839\u201340.","DOI":"10.1038\/42166"},{"key":"1748_CR14","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the \u03b1-synuclein gene identified in families with Parkinson\u2019s disease. Science. 1997;276:2045\u20137.","journal-title":"Science"},{"key":"1748_CR15","first-page":"588","volume":"60","author":"H Matsumine","year":"1997","unstructured":"Matsumine H, Saito M, Shimoda-Matsubayashi S, Tanaka H, Ishikawa A, Nakagawa-Hattori Y, et al. Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25. 2-27. Am J Hum Genet. 1997;60:588.","journal-title":"Am J Hum Genet"},{"key":"1748_CR16","doi-asserted-by":"crossref","unstructured":"Hatcher JM, Pennell KD, Miller GW. Parkinson\u2019s disease and pesticides: a toxicological perspective. Trends Pharmacol Sci. 2008;29:322\u20139.","DOI":"10.1016\/j.tips.2008.03.007"},{"key":"1748_CR17","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1289\/ehp.1002839","volume":"119","author":"CM Tanner","year":"2011","unstructured":"Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M, et al. Rotenone, paraquat, and Parkinson\u2019s disease. Environ Health Perspect. 2011;119:866\u201372.","journal-title":"Environ Health Perspect"},{"key":"1748_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrm.2016.140","volume":"18","author":"BR Sabari","year":"2017","unstructured":"Sabari BR, Zhang D, Allis CD, Zhao Y. Metabolic regulation of gene expression through histone acylations. Nat Rev Mol Cell Biol. 2017;18:90\u2013101.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1748_CR19","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/s41589-023-01267-9","volume":"19","author":"W Yu","year":"2023","unstructured":"Yu W, Zhou R, Li N, Lei Z-C, Guo D, Peng F, et al. Histone tyrosine sulfation by SULT1B1 regulates H4R3me2a and gene transcription. Nat Chem Biol. 2023;19:855\u201364.","journal-title":"Nat Chem Biol"},{"key":"1748_CR20","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1074\/jbc.M115.675488","volume":"291","author":"G Park","year":"2016","unstructured":"Park G, Tan J, Garcia G, Kang Y, Salvesen G, Zhang Z. Regulation of histone acetylation by autophagy in Parkinson disease. J Biol Chem. 2016;291:3531\u201340.","journal-title":"J Biol Chem"},{"key":"1748_CR21","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575\u201380.","journal-title":"Nature"},{"key":"1748_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s42255-022-00710-w","volume":"5","author":"Z Yang","year":"2023","unstructured":"Yang Z, Yan C, Ma J, Peng P, Ren X, Cai S, et al. Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma. Nat Metab. 2023;5:61\u201379.","journal-title":"Nat Metab"},{"key":"1748_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-021-02308-z","volume":"22","author":"J Yu","year":"2021","unstructured":"Yu J, Chai P, Xie M, Ge S, Ruan J, Fan X, et al. Histone lactylation drives oncogenesis by facilitating m 6 A reader protein YTHDF2 expression in ocular melanoma. Genome Biol. 2021;22:1\u201321.","journal-title":"Genome Biol"},{"key":"1748_CR24","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","volume":"82","author":"J Xiong","year":"2022","unstructured":"Xiong J, He J, Zhu J, Pan J, Liao W, Ye H, et al. Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells. Mol Cell. 2022;82:1660\u201377.e10.","journal-title":"Mol Cell"},{"key":"1748_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1165\/rcmb.2020-0360OC","volume":"64","author":"H Cui","year":"2021","unstructured":"Cui H, Xie N, Banerjee S, Ge J, Jiang D, Dey T, et al. Lung myofibroblasts promote macrophage profibrotic activity through lactate-induced histone lactylation. Am J Respir Cell Mol Biol. 2021;64:115\u201325.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1748_CR26","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/CIRCRESAHA.122.320488","volume":"131","author":"N Wang","year":"2022","unstructured":"Wang N, Wang W, Wang X, Mang G, Chen J, Yan X, et al. Histone lactylation boosts reparative gene activation post\u2013myocardial infarction. Circ Res. 2022;131:893\u2013908.","journal-title":"Circ Res"},{"key":"1748_CR27","doi-asserted-by":"crossref","unstructured":"Hagihara H, Shoji H, Otabi H, Toyoda A, Katoh K, Namihira M, et al. Protein lactylation induced by neural excitation. Cell Rep. 2021;37:109820.","DOI":"10.1016\/j.celrep.2021.109820"},{"key":"1748_CR28","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.cmet.2022.02.013","volume":"34","author":"R-Y Pan","year":"2022","unstructured":"Pan R-Y, He L, Zhang J, Liu X, Liao Y, Gao J, et al. Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in Alzheimer\u2019s disease. Cell Metab. 2022;34:634\u201348.e6.","journal-title":"Cell Metab"},{"key":"1748_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4103\/1673-5374.374142","volume":"19","author":"C Yang","year":"2024","unstructured":"Yang C, Pan R-Y, Guan F, Yuan Z. Lactate metabolism in neurodegenerative diseases. Neural Regen Res. 2024;19:69\u201374.","journal-title":"Neural Regen Res"},{"key":"1748_CR30","first-page":"61","volume":"16","author":"BC Bowen","year":"1995","unstructured":"Bowen BC, Block RE, Sanchez-Ramos J, Pattany PM, Lampman DA, Murdoch JB, et al. Proton MR spectroscopy of the brain in 14 patients with Parkinson disease. Am J Neuroradiol. 1995;16:61\u20138.","journal-title":"Am J Neuroradiol"},{"key":"1748_CR31","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3233\/JPD-212936","volume":"12","author":"C Liguori","year":"2022","unstructured":"Liguori C, Stefani A, Fernandes M, Cerroni R, Mercuri NB, Pierantozzi M. Biomarkers of cerebral glucose metabolism and neurodegeneration in Parkinson\u2019s disease: a cerebrospinal fluid-based study. J Parkinson\u2019s Dis. 2022;12:537\u201344.","journal-title":"J Parkinson\u2019s Dis"},{"key":"1748_CR32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.neurobiolaging.2020.02.012","volume":"90","author":"T Schirinzi","year":"2020","unstructured":"Schirinzi T, Di Lazzaro G, Sancesario GM, Summa S, Petrucci S, Colona VL, et al. Young-onset and late-onset Parkinson\u2019s disease exhibit a different profile of fluid biomarkers and clinical features. Neurobiol Aging. 2020;90:119\u201324.","journal-title":"Neurobiol Aging"},{"key":"1748_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-8-89","volume":"8","author":"AM Cervera","year":"2009","unstructured":"Cervera AM, Bayley J-P, Devilee P, McCreath KJ. Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells. Mol Cancer. 2009;8:1\u20137.","journal-title":"Mol Cancer"},{"key":"1748_CR34","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201948686","volume":"21","author":"H Han","year":"2020","unstructured":"Han H, Tan J, Wang R, Wan H, He Y, Yan X, et al. PINK1 phosphorylates Drp1 to regulate mitophagy-independent mitochondrial dynamics. EMBO Rep. 2020;21:e48686.","journal-title":"EMBO Rep"},{"key":"1748_CR35","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 2015;12:357\u201360.","journal-title":"Nat Methods"},{"key":"1748_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinf. 2011;12:1\u201316.","journal-title":"BMC Bioinf"},{"key":"1748_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:1\u201321.","journal-title":"Genome Biol"},{"key":"1748_CR38","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/wics.147","volume":"3","author":"H Wickham","year":"2011","unstructured":"Wickham H. ggplot2. Wiley Interdiscip Rev Comput Stat. 2011;3:180\u20135.","journal-title":"Wiley Interdiscip Rev Comput Stat"},{"key":"1748_CR39","doi-asserted-by":"crossref","unstructured":"Chunhong Y, Xiaoyun L, Fang C, Song M, Lu L, Honglu L, et al. ARID1A loss derepresses a group of human endogenous retrovirus-H loci to modulate BRD4-dependent transcription. Nat Commun. 2022;13:3501.","DOI":"10.1038\/s41467-022-31197-4"},{"key":"1748_CR40","doi-asserted-by":"crossref","unstructured":"Shen W, Le S, Li Y, Hu F. SeqKit: a cross-platform and ultrafast toolkit for FASTA\/Q file manipulation. PLoS One. 2016;11:e0163962.","DOI":"10.1371\/journal.pone.0163962"},{"key":"1748_CR41","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg S. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357\u20139.","journal-title":"Nat Methods"},{"key":"1748_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giab008","volume":"10","author":"P Danecek","year":"2021","unstructured":"Danecek P, Bonfield JK, Liddle J, Marshall J, Ohan V, Pollard MO, et al. Twelve years of SAMtools and BCFtools. GigaScience. 2021;10:giab008.","journal-title":"GigaScience"},{"key":"1748_CR43","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1038\/nprot.2012.101","volume":"7","author":"J Feng","year":"2012","unstructured":"Feng J, Liu T, Qin B, Zhang Y, Liu X. Identifying ChIP-seq enrichment using MACS. Nat Protoc. 2012;7:1728\u201340.","journal-title":"Nat Protoc"},{"key":"1748_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2012-13-3-r16","volume":"13","author":"Z Shao","year":"2012","unstructured":"Shao Z, Zhang Y, Yuan G, Orkin S, Waxman D. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets. Genome Biol. 2012;13:R16.","journal-title":"Genome Biol"},{"key":"1748_CR45","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L, Han Y, He Q. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284\u20137.","journal-title":"OMICS"},{"key":"1748_CR46","doi-asserted-by":"crossref","unstructured":"Tushar K, Abdulraouf A, Burris SJ, Jonah L, Vahid G, Naeem MN, et al. Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson\u2019s disease. Nat Neurosci. 2022;25:588\u201395.","DOI":"10.1038\/s41593-022-01061-1"},{"key":"1748_CR47","doi-asserted-by":"crossref","unstructured":"Jianbo C, Zhen W, Manpei T, Wen Z, Guozhong L, Senwei T, et al. KCTD10 regulates brain development by destabilizing brain disorder-associated protein KCTD13. Proc Natl Acad Sci USA. 2024;121:e2315707121.","DOI":"10.1073\/pnas.2315707121"},{"key":"1748_CR48","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3233\/JPD-230457","volume":"14","author":"J Gionco","year":"2024","unstructured":"Gionco J, Bernstein A. Emerging role of environmental epitranscriptomics and rna modifications in Parkinson\u2019s disease. J Parkinson\u2019s Dis. 2024;14:643\u201356.","journal-title":"J Parkinson\u2019s Dis"},{"key":"1748_CR49","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1111\/jcmm.13432","volume":"22","author":"W Hou","year":"2018","unstructured":"Hou W, Yin J, Alimujiang M, Yu X, Ai L, Bao Y, et al. Inhibition of mitochondrial complex I improves glucose metabolism independently of AMPK activation. J Cell Mol Med. 2018;22:1316\u201328.","journal-title":"J Cell Mol Med"},{"key":"1748_CR50","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/jnc.13731","volume":"139","author":"A Bose","year":"2016","unstructured":"Bose A, Beal MF. Mitochondrial dysfunction in Parkinson\u2019s disease. J Neurochem. 2016;139:216\u201331.","journal-title":"J Neurochem"},{"key":"1748_CR51","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.tibs.2020.11.007","volume":"46","author":"AB Malpartida","year":"2021","unstructured":"Malpartida AB, Williamson M, Narendra DP, Wade-Martins R, Ryan BJ. Mitochondrial dysfunction and mitophagy in Parkinson\u2019s disease: from mechanism to therapy. Trends Biochem Sci. 2021;46:329\u201343.","journal-title":"Trends Biochem Sci"},{"key":"1748_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11910-018-0829-3","volume":"18","author":"J-S Park","year":"2018","unstructured":"Park J-S, Davis RL, Sue CM. Mitochondrial dysfunction in Parkinson\u2019s disease: new mechanistic insights and therapeutic perspectives. Curr Neurol Neurosci Rep. 2018;18:1\u201311.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1748_CR53","doi-asserted-by":"publisher","first-page":"e44610","DOI":"10.1371\/journal.pone.0044610","volume":"7","author":"S Giordano","year":"2012","unstructured":"Giordano S, Lee J, Darley-Usmar VM, Zhang J. Distinct effects of rotenone, 1-methyl-4-phenylpyridinium and 6-hydroxydopamine on cellular bioenergetics and cell death. PLoS One. 2012;7:e44610.","journal-title":"PLoS One"},{"key":"1748_CR54","doi-asserted-by":"crossref","unstructured":"Fran\u00e7oise F, Michelle B, Audrey B, Christiane V, C\u00e9cile M, Marie-Th\u00e9r\u00e8se Z, et al. Differential effect of DCA treatment on the pyruvate dehydrogenase complex in patients with severe PDHC deficiency. Pediatr Res. 2003;53:793\u20139.","DOI":"10.1203\/01.PDR.0000057987.46622.64"},{"key":"1748_CR55","doi-asserted-by":"crossref","unstructured":"Morten KJ, Beattie P, Brown GK, Matthews PM. Dichloroacetate stabilizes the mutant E1alpha subunit in pyruvate dehydrogenase deficiency. Neurology. 1999;53:612\u20136.","DOI":"10.1212\/WNL.53.3.612"},{"key":"1748_CR56","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41421-022-00398-y","volume":"8","author":"H Zu","year":"2022","unstructured":"Zu H, Li C, Dai C, Pan Y, Ding C, Sun H, et al. SIRT2 functions as a histone delactylase and inhibits the proliferation and migration of neuroblastoma cells. Cell Discov. 2022;8:54.","journal-title":"Cell Discov"},{"key":"1748_CR57","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abi6696","volume":"8","author":"C Moreno-Yruela","year":"2022","unstructured":"Moreno-Yruela C, Zhang D, Wei W, B\u00e6k M, Liu W, Gao J, et al. Class I histone deacetylases (HDAC1\u20133) are histone lysine delactylases. Sci Adv. 2022;8:eabi6696.","journal-title":"Sci Adv"},{"key":"1748_CR58","doi-asserted-by":"publisher","first-page":"9996","DOI":"10.1523\/JNEUROSCI.3292-06.2006","volume":"26","author":"C Malagelada","year":"2006","unstructured":"Malagelada C, Ryu EJ, Biswas SC, Jackson-Lewis V, Greene LA. RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson\u2019s disease by a mechanism involving mammalian target of rapamycin inactivation. J Neurosci. 2006;26:9996\u201310005.","journal-title":"J Neurosci"},{"key":"1748_CR59","doi-asserted-by":"publisher","first-page":"14363","DOI":"10.1523\/JNEUROSCI.3928-08.2008","volume":"28","author":"C Malagelada","year":"2008","unstructured":"Malagelada C, Jin ZH, Greene LA. RTP801 is induced in Parkinson\u2019s disease and mediates neuron death by inhibiting Akt phosphorylation\/activation. J Neurosci. 2008;28:14363\u201371.","journal-title":"J Neurosci"},{"key":"1748_CR60","doi-asserted-by":"publisher","first-page":"58813","DOI":"10.18632\/oncotarget.11020","volume":"7","author":"M Canal","year":"2016","unstructured":"Canal M, Mart\u00edn-Flores N, P\u00e9rez-Sisqu\u00e9s L, Roman\u00ed-Aumedes J, Altas B, Man HY, et al. Loss of NEDD4 contributes to RTP801 elevation and neuron toxicity: implications for Parkinson\u2019s disease. Oncotarget. 2016;7:58813.","journal-title":"Oncotarget"},{"key":"1748_CR61","doi-asserted-by":"publisher","first-page":"e1364","DOI":"10.1038\/cddis.2014.333","volume":"5","author":"J Roman\u00ed-Aumedes","year":"2014","unstructured":"Roman\u00ed-Aumedes J, Canal M, Mart\u00edn-Flores N, Sun X, P\u00e9rez-Fern\u00e1ndez V, Wewering S, et al. Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson\u2019s disease. Cell Death Dis. 2014;5:e1364\u2013e.","journal-title":"Cell Death Dis"},{"key":"1748_CR62","doi-asserted-by":"crossref","unstructured":"Peter W S, Douglas S K, Carie B, S Terri B, Paul R C, et al. Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children. Pediatrics. 2006;117:1519\u201331.","DOI":"10.1542\/peds.2005-1226"},{"key":"1748_CR63","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.addr.2008.02.014","volume":"60","author":"WS Peter","year":"2008","unstructured":"Peter WS, Tracie LK, Zongchao H, Taimour L. Role of dichloroacetate in the treatment of genetic mitochondrial diseases. Adv Drug Deliv Rev. 2008;60:1478\u201387.","journal-title":"Adv Drug Deliv Rev"},{"key":"1748_CR64","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1371\/journal.pgen.0030098","volume":"3","author":"TG Lesnick","year":"2007","unstructured":"Lesnick TG, Papapetropoulos S, Mash DC, Ffrench-Mullen J, Shehadeh L, De Andrade M, et al. A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet. 2007;3:e98.","journal-title":"PLoS Genet"},{"key":"1748_CR65","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.molbrainres.2004.09.017","volume":"134","author":"RJ Smeyne","year":"2005","unstructured":"Smeyne RJ, Jackson-Lewis V. The MPTP model of Parkinson\u2019s disease. Mol Brain Res. 2005;134:57\u201366.","journal-title":"Mol Brain Res"},{"key":"1748_CR66","doi-asserted-by":"publisher","first-page":"10756","DOI":"10.1523\/JNEUROSCI.23-34-10756.2003","volume":"23","author":"TB Sherer","year":"2003","unstructured":"Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, Kim JH, et al. Mechanism of toxicity in rotenone models of Parkinson\u2019s disease. J Neurosci. 2003;23:10756\u201364.","journal-title":"J Neurosci"},{"key":"1748_CR67","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1566-2772(01)00019-6","volume":"1","author":"S Przedborski","year":"2001","unstructured":"Przedborski S, Vila M. MPTP: a review of its mechanisms of neurotoxicity. Clin Neurosci Res. 2001;1:407\u201318.","journal-title":"Clin Neurosci Res"},{"key":"1748_CR68","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3109\/10408444.2012.680431","volume":"42","author":"N Xiong","year":"2012","unstructured":"Xiong N, Long X, Xiong J, Jia M, Chen C, Huang J, et al. Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson\u2019s disease models. Crit Rev Toxicol. 2012;42:613\u201332.","journal-title":"Crit Rev Toxicol"},{"key":"1748_CR69","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","volume":"54","author":"A Schapira","year":"1990","unstructured":"Schapira A, Cooper J, Dexter D, Clark J, Jenner P, Marsden C. Mitochondrial complex I deficiency in Parkinson\u2019s disease. J Neurochem. 1990;54:823\u20137.","journal-title":"J Neurochem"},{"key":"1748_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00450-7","volume":"16","author":"L Toker","year":"2021","unstructured":"Toker L, Tran G, Sundaresan J, Tysnes O, Alves G, Haugarvoll K, et al. Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson\u2019s disease brain. Mol Neurodegener. 2021;16:31.","journal-title":"Mol Neurodegener"},{"key":"1748_CR71","doi-asserted-by":"crossref","unstructured":"Huang M, Lou D, Charli A, Kong D, Jin H, Zenitsky G, et al. Mitochondrial dysfunction-induced H3K27 hyperacetylation perturbs enhancers in Parkinson\u2019s disease. JCI insight. 2021;6:e138088.","DOI":"10.1172\/jci.insight.138088"},{"key":"1748_CR72","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41419-020-03105-5","volume":"11","author":"M Mu","year":"2020","unstructured":"Mu M, Qian Z, Yang S, Rong K, Yung W, Ke Y. Therapeutic effect of a histone demethylase inhibitor in Parkinson\u2019s disease. Cell Death Dis. 2020;11:927.","journal-title":"Cell Death Dis"},{"key":"1748_CR73","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012188","volume":"13","author":"S Guhathakurta","year":"2021","unstructured":"Guhathakurta S, Kim J, Adams L, Basu S, Song M, Adler E, et al. Targeted attenuation of elevated histone marks at SNCA alleviates \u03b1-synuclein in Parkinson\u2019s disease. EMBO Mol Med. 2021;13:e12188.","journal-title":"EMBO Mol Med"},{"key":"1748_CR74","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1007\/s12035-021-02298-w","volume":"58","author":"H Zhang","year":"2021","unstructured":"Zhang H, Wang J, Li Z, Cui L, Huang S, Zhu L, et al. DNA methyltransferase 1 is dysregulated in Parkinson\u2019s disease via mediation of miR-17. Mol Neurobiol. 2021;58:2620\u201333.","journal-title":"Mol Neurobiol"},{"key":"1748_CR75","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1007\/s11011-021-00840-2","volume":"36","author":"A Pathania","year":"2021","unstructured":"Pathania A, Garg P, Sandhir R. Impaired mitochondrial functions and energy metabolism in MPTP-induced Parkinson\u2019s disease: comparison of mice strains and dose regimens. Metab Brain Dis. 2021;36:2343\u201357.","journal-title":"Metab Brain Dis"},{"key":"1748_CR76","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.bbrc.2017.05.162","volume":"489","author":"Y Miki","year":"2017","unstructured":"Miki Y, Tanji K, Mori F, Kakita A, Takahashi H, Wakabayashi K. Alteration of mitochondrial protein PDHA1 in Lewy body disease and PARK14. Biochem Biophys Res Commun. 2017;489:439\u201344.","journal-title":"Biochem Biophys Res Commun"},{"key":"1748_CR77","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s42255-020-0243-4","volume":"2","author":"JD Rabinowitz","year":"2020","unstructured":"Rabinowitz JD, Enerb\u00e4ck S. Lactate: the ugly duckling of energy metabolism. Nat Metab. 2020;2:566\u201371.","journal-title":"Nat Metab"},{"key":"1748_CR78","doi-asserted-by":"publisher","first-page":"7477","DOI":"10.1523\/JNEUROSCI.0415-11.2011","volume":"31","author":"MT Wyss","year":"2011","unstructured":"Wyss MT, Jolivet R, Buck A, Magistretti PJ, Weber B. In vivo evidence for lactate as a neuronal energy source. J Neurosci. 2011;31:7477\u201385.","journal-title":"J Neurosci"},{"key":"1748_CR79","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/jcbfm.2015.77","volume":"35","author":"V Mosienko","year":"2015","unstructured":"Mosienko V, Teschemacher AG, Kasparov S. Is L-lactate a novel signaling molecule in the brain? J Cereb Blood Flow Metab. 2015;35:1069\u201375.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1748_CR80","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/jcbfm.2011.149","volume":"32","author":"L Pellerin","year":"2012","unstructured":"Pellerin L, Magistretti PJ. Sweet sixteen for ANLS. J Cereb Blood Flow Metab. 2012;32:1152\u201366.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1748_CR81","doi-asserted-by":"crossref","unstructured":"Shoshani T, Faerman A, Mett I, Zelin E, Tenne T, Gorodin S, et al. Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol Cell Biol. 2002;22:2283\u201393.","DOI":"10.1128\/MCB.22.7.2283-2293.2002"},{"key":"1748_CR82","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S1097-2765(02)00706-2","volume":"10","author":"LW Ellisen","year":"2002","unstructured":"Ellisen LW, Ramsayer KD, Johannessen CM, Yang A, Beppu H, Minda K, et al. REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol Cell. 2002;10:995\u20131005.","journal-title":"Mol Cell"},{"key":"1748_CR83","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1007\/s13311-019-00826-0","volume":"17","author":"K-H Ho","year":"2020","unstructured":"Ho KH, Chen PH, Chou CM, Shih CM, Lee YT, Cheng CH, et al. A key role of DNA damage-inducible transcript 4 (DDIT4) connects autophagy and GLUT3-mediated stemness to desensitize temozolomide efficacy in glioblastomas. Neurotherapeutics. 2020;17:1212\u201327.","journal-title":"Neurotherapeutics"},{"key":"1748_CR84","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/bph.14091","volume":"175","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Chu SF, Wang SS, Jiang YN, Gao Y, Yang PF, et al. RTP801 is a critical factor in the neurodegeneration process of A53T \u03b1-synuclein in a mouse model of Parkinson\u2019s disease under chronic restraint stress. Br J Pharmacol. 2018;175:590\u2013605.","journal-title":"Br J Pharmacol"},{"key":"1748_CR85","doi-asserted-by":"publisher","unstructured":"Wang SS, Yuan RL, Wang WF, Peng Y, Hu KC, He WB, et al. Spike RBD drives sustained Parkinson\u2019s disease progression via microglia-neuron crosstalk-mediated RTP801 upregulation. J Adv Res. 2025. https:\/\/doi.org\/10.1016\/j.jare.2025.07.060.","DOI":"10.1016\/j.jare.2025.07.060"},{"key":"1748_CR86","doi-asserted-by":"crossref","unstructured":"Wang SS, Peng Y, Fan PL, Ye JR, Ma WY, Wu QL, et al. Ginsenoside Rg1 ameliorates stress-exacerbated Parkinson\u2019s disease in mice by eliminating RTP801 and \u03b1-synuclein autophagic degradation obstacle. Acta Pharmacol Sin. 2025;46:308\u201325.","DOI":"10.1038\/s41401-024-01374-w"},{"key":"1748_CR87","doi-asserted-by":"publisher","first-page":"105605","DOI":"10.1016\/j.nbd.2021.105605","volume":"163","author":"J Li","year":"2022","unstructured":"Li J, Chen L, Qin Q, Wang D, Zhao J, Gao H, et al. Upregulated hexokinase 2 expression induces the apoptosis of dopaminergic neurons by promoting lactate production in Parkinson\u2019s disease. Neurobiol Dis. 2022;163:105605.","journal-title":"Neurobiol Dis"},{"key":"1748_CR88","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41531-024-00858-0","volume":"11","author":"Q Qin","year":"2025","unstructured":"Qin Q, Wang D, Qu Y, Li J, An K, Mao Z, et al. Enhanced glycolysis-derived lactate promotes microglial activation in Parkinson\u2019s disease via histone lactylation. NPJ Parkinsons Dis. 2025;11:3.","journal-title":"NPJ Parkinsons Dis"},{"key":"1748_CR89","doi-asserted-by":"crossref","unstructured":"Lian B, Zhang J, Yin X, Wang J, Li L, Ju Q, et al. SIRT1 improves lactate homeostasis in the brain to alleviate parkinsonism via deacetylation and inhibition of PKM2. Cell Rep Med. 2024;5:101684.","DOI":"10.1016\/j.xcrm.2024.101684"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01748-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01748-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01748-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T09:02:16Z","timestamp":1779440536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01748-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":89,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1748"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01748-2","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"31 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}